logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

Amura Therapeutics Limited


USPTO Granted Patents = 15

% Expired Patents = 93.3


Forward Citations = 7

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Martin Quibell (15 out of 20 patents)

silverMedal John Paul Watts (12 out of 14 patents)

bronzeMedal Nicholas Sean Flinn (3 out of 4 patents)

4.  Lee Patient (1 out of 17 patents)

5.  Claudio Dagostin (1 out of 6 patents)

6.  James Nally (1 out of 1 patent)

7.  Yikang Wang (1 out of 1 patent)

8.  Manoj Kumar Ramjee (1 out of 2 patents)


15 patents:

1. 9045492 - Piperazine compounds (2015-06-02),
2. 8552202 - Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors (2013-10-08),
3. 8501744 - Piperazine compounds (2013-08-06),
4. 8389737 - Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors (2013-03-05),
5. 8053437 - Furo[3. 2-B] pyrrol derivatives (2011-11-08),
6. 8039641 - Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates (2011-10-18),
7. 8008290 - Compounds (2011-08-30),
8. 7846935 - Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors (2010-12-07),
9. 7846934 - Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors (2010-12-07),
10. 7803803 - Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitors (2010-09-28),
11. 7799791 - Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases (2010-09-21),
12. 7737150 - Furo[3, 2-b] pyrrol derivatives (2010-06-15),
13. 7425562 - Inhibitors of cruzipain and other cysteine proteases (2008-09-16),
14. 7132449 - Inhibitors of cruzipain and other cysteine proteases (2006-11-07),
15. 6958358 - Inhibitors of cruzipain and other cysteine proteases (2005-10-25),
Company Overview
Amura Therapeutics Limited is a biotechnology company based in Cambridge, UK, focused on the development of innovative therapies for the treatment of various diseases. The organization specializes in advanced drug discovery and development, leveraging cutting-edge technologies to create novel therapeutic solutions. With a commitment to addressing unmet medical needs, Amura Therapeutics is dedicated to advancing healthcare through its research in biopharmaceuticals and targeted therapies, aiming to improve patient outcomes globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#72 in Cambridge

#1,184 in United Kingdom

#39,921 in the World

Cambridge, GB
Cambridge, United Kingdom

Amura Therapeutics Limited

Forward Citations = 7

8 inventors:

goldMedal Martin Quibell (15 out of 20 patents)

silverMedal John Paul Watts (12 out of 14 patents)

bronzeMedal Nicholas Sean Flinn (3 out of 4 patents)

4.  Lee Patient (1 out of 17 patents)

5.  Claudio Dagostin (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amura Therapeutics Limited. Retrieved from https://idiyas.com/company/amura-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…